These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 629810)

  • 1. Effect of metabolic inhibitors and ouabain on amphetamine- and potassium-induced release of biogenic amines from isolated brain tissue.
    Rutledge CO
    Biochem Pharmacol; 1978 Feb; 27(4):511-6. PubMed ID: 629810
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of neuronal uptake of amines for amphetamine-induced release of 3H-norepinephrine from isolated brain tissue.
    Azzaro AJ; Ziance RJ; Rutledge CO
    J Pharmacol Exp Ther; 1974 Apr; 189(1):110-8. PubMed ID: 4823286
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of transport for the uptake and release of biogenic amines in nerve endings.
    Bogdanski DF
    Adv Exp Med Biol; 1976; 69():291-305. PubMed ID: 133592
    [No Abstract]   [Full Text] [Related]  

  • 4. The interaction between female sex hormones and D-amphetamine on central biogenic amines during the rat oestrous cycle.
    Fludder JM; Tonge SR
    Ir J Med Sci; 1978 Aug; 147 Suppl 1():28-32. PubMed ID: 567630
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of four amphetamines on brain biogenic amines and their metabolites.
    Leonard BE
    Biochem Pharmacol; 1972 May; 21(9):1289-97. PubMed ID: 5038674
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative regulation of potassium and amphetamine induced release of 3H-norepinephrine from rat brain via presynaptic mechanisms.
    Shenoy AK; Ziance RJ
    Life Sci; 1979 Jan; 24(3):255-64. PubMed ID: 423704
    [No Abstract]   [Full Text] [Related]  

  • 7. d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes.
    Raiteri M; Bertollini A; Angelini F; Levi G
    Eur J Pharmacol; 1975 Nov; 34(1):189-95. PubMed ID: 1234761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the effect of K+, G-strophantin and metabolic inhibitors upon the steady potential and impedance of the brain tissue in chick embryos.
    Sedlácek J
    Physiol Bohemoslov; 1967; 16(4):350-7. PubMed ID: 4228113
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of amphetamine on brain biogenic amines in isolated and aggregated rats.
    Lokiec F; Jacquot C; Rapin JR; Cohen Y
    Eur J Pharmacol; 1977 Aug; 44(4):391-5. PubMed ID: 891613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of prenatal d-amphetamine administration on development and behavior of rats.
    Hitzemann BA; Hitzemann RJ; Brase DA; Loh HH
    Life Sci; 1976 Mar; 18(6):605-12. PubMed ID: 1263744
    [No Abstract]   [Full Text] [Related]  

  • 11. Conjugates of biogenic amines in ventriculocisternal perfusates of conscious African green monkeys.
    Tyce GM; Yaksh TL
    Brain Res; 1986 May; 372(2):269-76. PubMed ID: 3708364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pargyline and desmethylimipramine on monoamine concentrations and amphetamine-induced glycogenolysis in the mouse brain.
    Hutchins DA
    Br J Pharmacol; 1979 Mar; 65(3):489-94. PubMed ID: 427324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of metabolic inhibitors on amino acid uptake and the levels of ATP, Na+, and K+ in incubated slices of mouse brain.
    Banay-Schwartz M; Teller DN; Gergely A; Lajtha A
    Brain Res; 1974 May; 71(1):117-31. PubMed ID: 4132385
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine.
    Taylor D; Ho BT
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):67-75. PubMed ID: 684280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting the release of purines from mouse cerebral cortex: potassium removal and metabolic inhibitors.
    Lloyd HG; Stone TW
    Biochem Pharmacol; 1981 Jun; 30(11):1239-43. PubMed ID: 7271823
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of membrane depolarization and biogenic amines on the formation of cyclic AMP in incubated brain slices.
    Shimizu H; Creveling CR; Daly JW
    Adv Biochem Psychopharmacol; 1970; 3():135-54. PubMed ID: 4331454
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropsychopharmacology of monoamines and their regulatory enzymes.
    Lipton MA
    Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of amphetamine and apomorphine on brain monoamines and behaviour in the immature and young adult rat.
    Lal S; Feldmüller F
    Arch Int Pharmacodyn Ther; 1975 Dec; 218(2):239-51. PubMed ID: 1212022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of brain monoamines in the anorectic activity of mazindol and d-amphetamine in the rat.
    Samanin R; Bendotti C; Bernasconi S; Borroni E; Garattini S
    Eur J Pharmacol; 1977 May; 43(2):117-24. PubMed ID: 872869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatase activity in particulate fractions of rat brain. Effect of cations and biogenic amines in vitro studies.
    Formby B; Clausen J
    Hoppe Seylers Z Physiol Chem; 1968 Mar; 349(3):349-56. PubMed ID: 5725546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.